ask="2.97"
ask_size="6500"
average_daily_volume="1030200"
bid="2.85"
bid_size="300"
book_value="0.34"
change="-0.01"
change_from_200_day_moving_average="1.20"
change_from_50_day_moving_average="0.96"
change_from_52_week_high="-1.30"
change_From_52_week_low="1.80"
change_in_percent="-0.34%"
close="2.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-0.99"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-0.95"
ex_dividend_date="N/A"
float_shares="4441000"
high="3.10"
high_52_weeks="4.21"
last_trade_date="3/6/2017"
last_trade_price="2.91"
last_trade_size="949"
last_trade_time="4:00pm"
low="2.82"
low_52_weeks="1.11"
market_capitalization="27.89M"
moving_average_200_day="1.71"
moving_average_50_day="1.95"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+69.76%"
percent_change_from_50_day_moving_average="+49.22%"
percent_change_from_52_week_high="-30.88%"
percent_change_from_52_week_low="+162.16%"
previous_close="2.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.61"
price_per_sales="55.00"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="1.02"
stock_exchange="NCM"
symbol="EYEG"
volume="1260311"
weeks_range_52="1.11 - 4.21"
